Department of Biomedical Engineering, National Cheng Kung University Hospital, Taiwan.
Cancer Res. 2013 Jul 15;73(14):4500-9. doi: 10.1158/0008-5472.CAN-12-4127. Epub 2013 May 22.
Stromal-interaction molecule 1 (STIM1) is an endoplasmic reticulum Ca(2+) storage sensor that promotes cell growth, migration, and angiogenesis in breast and cervical cancers. Here, we report that the microtubule-associated histone deacetylase 6 (HDAC6) differentially regulates activation of STIM1-mediated store-operated Ca(2+) entry (SOCE) between cervical cancer cells and normal cervical epithelial cells. Confocal microscopy of living cells indicated that microtubule integrity was necessary for STIM1 trafficking to the plasma membrane and interaction with Orai1, an essential pore subunit of SOCE. Cancer cells overexpressed both STIM1 and Orai1 compared with normal cervical epithelial cells. HDAC6 upregulation in cancer cells was accompanied by hypoacetylated α-tubulin. Tubastatin-A, a specific HDAC6 inhibitor, inhibited STIM1 translocation to plasma membrane and blocked SOCE activation in cancer cells but not normal epithelial cells. Genetic or pharmacologic inhibition of HDAC6 blocked STIM1 membrane trafficking and downstream Ca(2+) influx, as evidenced by total internal reflection fluorescent images and intracellular Ca(2+) determination. In contrast, HDAC6 inhibition did not affect interactions between STIM1 and the microtubule plus end-binding protein EB1. Analysis of surgical specimens confirmed that most cervical cancer tissues overexpressed STIM1 and Orai1, accompanied by hypoacetylated α-tubulin. Together, our results identify HDAC6 as a candidate target to disrupt STIM1-mediated SOCE as a general strategy to block malignant cell behavior.
基质相互作用分子 1(STIM1)是内质网 Ca2+储存传感器,可促进乳腺癌和宫颈癌中的细胞生长、迁移和血管生成。在这里,我们报告微管相关组蛋白去乙酰化酶 6(HDAC6)可调节宫颈癌和正常宫颈上皮细胞之间 STIM1 介导的储存操纵的 Ca2+内流(SOCE)的激活。活细胞的共焦显微镜表明微管完整性对于 STIM1 向质膜的运输和与 SOCE 的必需孔亚基 Orai1 的相互作用是必需的。与正常宫颈上皮细胞相比,癌细胞中同时过表达了 STIM1 和 Orai1。与正常宫颈上皮细胞相比,癌细胞中 HDAC6 的上调伴随着α-微管蛋白的低乙酰化。特异性 HDAC6 抑制剂 tubastatin-A 抑制了癌细胞中 STIM1 向质膜的易位和 SOCE 的激活,但对正常上皮细胞没有作用。HDAC6 的遗传或药理学抑制阻断了 STIM1 的膜转运和下游 Ca2+内流,这可以通过全内反射荧光图像和细胞内 Ca2+测定来证明。相比之下,HDAC6 抑制不影响 STIM1 与微管末端结合蛋白 EB1 之间的相互作用。手术标本的分析证实,大多数宫颈癌组织过表达 STIM1 和 Orai1,并伴随着α-微管蛋白的低乙酰化。总之,我们的结果确定了 HDAC6 作为一种候选靶点,可破坏 STIM1 介导的 SOCE,作为阻断恶性细胞行为的一般策略。